Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol:
HGF
Name:
hepatocyte growth factor
Location:
07q21.11
Locus Group:
protein-coding gene
Gene Type:
Protein Coding
Locus Type:
gene with protein product
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all
Clinical Studies
| NCT Number | Status | Brief Title | View |
|---|---|---|---|
| NCT00364715 | Study the Expression of Annexin A1 and Its Potential Usage as a Prognostic Marker in Oral Cancer | View | |
| NCT00478127 | Hepatocyte Growth Factor and Cardiovascular Autonomic Function | View | |
| NCT04234750 | Mesenchymal Stem Cell-derived Pleiotropic Factor in the Treatment of Donor Sites | View | |
| NCT02193334 | Phase III Study of KP-100IT in Acute Spinal Cord Injury | View | |
| NCT02277197 | Ficlatuzumab and Cetuximab in RecurrentMetastatic Head and Neck Squamous Cell Carcinoma HNSCC | View | |
| NCT02277184 | Ficlatuzumab Cisplatin and IMRT in Locally Advanced Head and Neck Squamous Cell Carcinoma | View | |
| NCT02296879 | A Multicenter Open Label Phase I Dose Escalation Study to Evaluate the Safety Tolerability and Pharmacokinetics of Intravenous SAIT301 in Subjects With Advanced c-MET Positive Solid Tumors Followed by Expansion in Selected Tumor Types | View | |
| NCT03668353 | Recombinant SeV-hFGF2dF Injection for PAOD | View | |
| NCT04822818 | EFFICACY and SAFETY OF BEVACIZUMAB ZIRABEV IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19 | View | |
| NCT05882292 | A Phase II Study of ABN401 in Advanced Solid Tumors With c-MET Gene Aberration | View | |
| NCT03205085 | Determinants of Right Heart Remodeling in Patients With CTEPH or PAH | View | |
| NCT05246774 | Study of Serum and Urinary Biomarkers and Radiation Cystitis in Patients Treated With Radiotherapy for Localized Prostate Cancer | View | |
| NCT04334044 | Treatment of SARS Caused by COVID-19 With Ruxolitinib | View | |
| NCT04368507 | To Evaluate the Safety Tolerability Pharmacokinetics and Antitumor Activity of YYB101 With Irinotecan Patients Who Are Metastatic or Recurrent Colorectal Cancer Patients | View | |
| NCT01697163 | De Novo Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors | View | |
| NCT00477074 | Pulmonary and Systemic Hepatocyte Growth Factors in Patients With COPD | View | |
| NCT02002416 | Prognostic Value and Clinical Pathology of c-MET Expression and Amplification in Gastric Carcinoma | View | |
| NCT00676793 | A Study of the Effect of Polyphenon E Green Tea Extract on Breast Cancer Progression | View | |
| NCT01163058 | Tyrosine Kinase Inhibitors In Metastatic Non Small Cell Lung Cancer | View | |
| NCT01233336 | Hepatocyte Growth Factor HGF Concentration in Myocardial Infarction | View | |
| NCT01569256 | Ovarian Hyperstimulation Syndrome and Cabergoline | View | |
| NCT01925352 | Safety Study of Adenovirus Hepatocyte Growth Factor to Treat Ischemic Heart Disease | View | |
| NCT02016755 | A Phase IIB Pilot Study of a Modified Dosage Regimen of AMG0001 in Subjects With Critical Limb Ischemia | View | |
| NCT03252028 | Rapid Test for Detection of the Focus of Infection in Post Neurosurgical Patients | View | |
| NCT03256604 | A Sputum Screening Test to Rule-out Pneumonia at an Early Stage | View | |
| NCT02449551 | Study of AZD6094 Volitinib in Advanced Gastric Adenocarcinoma Patients With MET Amplification as a Third-line Treatment | View | |
| NCT02499224 | Safety and Pharmacokinetics Study of YYB101 in Advanced Solid Tumors Patients Who Are Refractory to Standard Therapy | View | |
| NCT02844283 | Ad-HGF Treatment for Myocardial Infarction | View | |
| NCT03136653 | A Phase 2 Trial of MP0250 Plus Bortezomib Dexamethasone in Patients With Multiple Myeloma | View | |
| NCT04588051 | Cabozantinib in Hepatocellular Carcinoma | View | |
| NCT03457376 | Correlation of the Hand Grip Force With Maximum Inspiratory and Maximum Expiratory Pressure in Critical Ill Patients | View | |
| NCT04810585 | Plasma Biomarker for Aflibercept in Advanced Colorectal Cancer | View | |
| NCT04077099 | A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor MET-Altered Advanced Non-Small Cell Lung Cancer | View | |
| NCT04267640 | Study of AMG0001 to Improve Ulcer Healing and Perfusion in Subjects With Peripheral Ischemic Ulcers | View | |
| NCT04274049 | Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia NL003-CLI-III-2 | View | |
| NCT04275323 | Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia NL003-CLI-III-1 | View | |
| NCT04475224 | Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord Injury | View | |
| NCT01523652 | Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients | View | |
| NCT02394886 | Safety of ALLO-ASC-DFU in the Patients With Diabetic Foot Ulcers | View | |
| NCT05627648 | Phase 3 Study of KP-100LI in Subjects With Vocal Fold Scar | View | |
| NCT01999972 | A Phase 1b Study Of Axitinib In Combination With Crizotinib In Patients With Advanced Solid Tumors | View | |
| NCT02394873 | A Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Deep Second-degree Burn Wound | View | |
| NCT05968118 | Angiogenesis and Blood Perfusion Effect of HGF Gene Therapy in PAD Patients | View | |
| NCT00189540 | Study of Hepatocyte Growth Factor HGF Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers | View | |
| NCT00725764 | Phase 2 Study of GSK1363089 Formerly XL880 in Adults With Squamous Cell Cancer of the Head and Neck | View | |
| NCT02111005 | Smoking Influence on Apoptosis in Periodontitis | View | |
| NCT00060892 | Study of HGF Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia | View | |
| NCT02705573 | Effects of Mannitol on Delayed Graft Function After Cadaveric Renal Transplantation | View | |
| NCT01548378 | Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia | View | |
| NCT02254798 | Biomarkers for Acute Graft-versus-host Disease | View | |
| NCT01441388 | A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors | View | |
| NCT01542437 | Treatment With BIBW 2992 Irreversible Inhibitor of EGFR and HER-2 in Non-small Cell Lung Cancer | View | |
| NCT00104026 | Genes Associated With Hereditary and Drug-Induced Gingival Overgrowth | View | |
| NCT00844987 | Vascular Endothelial Growth Factor VEGF Platelet Derived Growth Factor PDGF Hepatocyte Growth Factor HGF in Patients With Acute Coronary Syndrome ACS | View | |
| NCT02926638 | Lung-MAP Rilotumumab and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches | View | |
| NCT03175224 | APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors | View | |
| NCT03418532 | MP0250 DARPin Protein Plus Osimertinib in Patients With EGFR-mutated NSCLC | View | |
| NCT03612232 | Cabozantinib in Advanced Adrenocortical Carcinoma | View | |
| NCT03867851 | Study to Evaluate Safety and Efficacy of IBsolvMIR in Islet Transplantation | View |